NCT07316894招募中不适用
International Delphi Consensus on the Universal Definition and Diagnosis of Iatrogenic Withdrawal Syndrome in Adult ICU Patients
ELIAS Emergency University Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年12月13日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Diagnostic Criteria of IWS
研究概览
简要总结
This is an International Delphi Consensus on the Definition and Diagnosis of Iatrogenic Withdrawal Syndrome in adult critically ill patients. It involves the anonymous completion of a questionnaire using a 7-point Likert scale.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •At least 5 years of experience or training or research in the field of Intensive Care Medicine, Anesthesiology or Psychiatry
排除标准
- •Not a specialist in the fields of Intensive Care Medicine, Anesthesiology or Psychiatry
结局指标
主要结局
Diagnostic Criteria of IWS
时间窗: 4 monts
The diagnostic criteria of IWS will be determined based on the items reaching the consensus
次要结局
未报告次要终点
研究者
Emanuel Moisa
MD, PhD, DESAIC, Assistant Professor and Specialist of Anaesthesia and Critical Care Medicine,
ELIAS Emergency University Hospital
研究点 (1)
Loading locations...
相似试验
招募中
3 期
STOP-I-SEP_Disease modifying therapies withdrawal in inactive Secondary Progressive Multiple Sclerosis patients older than 50 yearsMultiple Sclerosis2024-516628-32-00Centre Hospitalier Universitaire De Rennes250
招募中
3 期
DISEASE MODIFYING THERAPIES WITHDRAWAL IN INACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS AGED 55 AND OVER: A MULTICENTRIC, RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL - TWINSMultiple Sclerosis2024-513475-41-00Les Hopitaux Universitaires De Strasbourg200
招募中
4 期
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: (REMOVE)Heart Failure2023-504946-70-00Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia60
招募中
4 期
"SAFE DISCONTINUATION OF ANTIDEPRESSANTS IN INDIVIDUALS WITH CLINICALLY REMITTED DEPRESSIVE DISORDERS"2023-509377-23-00Universita Degli Studi Di Verona150
招募中
2 期
A trial to learn how safe saruparib is and how well it works in people with advanced ovarian cancer2024-519044-32-00AstraZeneca AB16